WebBNN Markets: Stocks, Canadian markets data, North American markets, S&P, TSX, Nasdaq, Venture WebApr 3, 2024 · MONTREAL, April 03, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it will report financial results for its first quarter 2024 ended February 28, on Wednesday, April …
5th Largest Copper Project in the World: Solgold (TSX: SOLG
WebSep 10, 2024 · (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it plans to pursue Phase 3 clinical development of tesamorelin for the treatment of Non-Alcoholic Steatohepatitis (NASH) in the general population. Web1 day ago · The benchmark S&P/TSX Composite Index, which stayed positive right through the day's session, ended with a gain of 110.17 points or 0.54% at 20,564.49, a new one-month closing high. pop up camper heater
2024-10-12 TSX:TH Press Release Theratechnologies Inc.
WebTheratechnologies Receives Nasdaq Notification Letter Regarding Share Price. MONTREAL, March 07, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced receipt of ... WebDec 1, 2024 · Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Web1 day ago · Losses were -47.24 million, 48.9% more than in 2024. According to 13 analysts, the average rating for THTX stock is "Buy." The 12-month stock price forecast is $3.9, which is an increase of 381.48% from the latest price. sharon knox solicitor